FDA Approves TRAMADOL HYDROCHLORIDE — Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals has been granted approval by the FDA for the 50 mg oral tablets of TRAMADOL HYDROCHLORIDE, positioning the company to expand its reach into the widespread analgesic market and enhance competitive pressure on branded formulations.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed